My opinion is still very much the same. I'm excited to hear how the Multiple Myeloma stuff goes towards end of Q3.
Mediq relationship, the new (more experienced) CFO, the filing of a patent(s) in USA and Europe... They're all more obvious signs that OWCP is a real-deal company and will soon be a Revenue generating, profitable company.